Lurker Nancy insider trades
Lurker Nancy has filed 36 Form 4s with the SEC that we hold, for EyePoint, Inc. (EYPT) (Director), Alkermes plc. (ALKS) (Director) and Collegium Pharmaceutical, INC (COLL) (Director). Across all of them we count 1 purchase worth $25.0K and 8 sales worth $1.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($312.9K). The largest single trade was a sale of 29,956 shares of EyePoint, Inc. worth $748.3K, dated 2024-01-24. The first filing on our record is dated 2021-11-17 and the latest 2026-05-22.
EyePoint, Inc. (EYPT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-11-15 | S, sale reported on Form 4 | 10,000 | $201.5K | 2021-11-17 | SEC |
| 2023-12-04 | S, sale reported on Form 4 | 20,000 | $415.2K | 2023-12-06 | SEC |
| 2024-01-23 | S, sale reported on Form 4 | 5,044 | $125.9K | 2024-01-25 | SEC |
| 2024-01-24 | S, sale reported on Form 4 | 29,956 | $748.3K | 2024-01-25 | SEC |
| 2024-08-16 | P, purchase reported on Form 4 | 3,173 | $25.0K | 2024-08-20 | SEC |
| 2025-11-26 | S, sale reported on Form 4 | 200 | $3.0K | 2025-12-01 | SEC |
| 2025-11-28 | S, sale reported on Form 4 | 500 | $7.5K | 2025-12-01 | SEC |
| 2025-12-04 | S, sale reported on Form 4 | 9,300 | $140.5K | 2025-12-05 | SEC |
Alkermes plc. (ALKS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Collegium Pharmaceutical, INC (COLL)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-05-13 | S, sale reported on Form 4 | 4,500 | $161.9K | 2026-05-15 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1450485) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
